| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | Vice President - Accounting | Stock Option (Right to Buy) | 6,161 | $408,474 | $66.30 | 02 Aug 2021 | Direct |
| Apellis Pharmaceuticals, Inc. | Vice President - Accounting | Common Stock | 4,847 | $308,705 | $63.69 | 02 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 02 Aug 2021 | 3 | -$60,230 | 4 | Vice President - Accounting | 03 Aug 2021, 16:23 |
| APLS | Apellis Pharmaceuticals, Inc. | 01 Jul 2021 | 3 | -$60,240 | 4 | Vice President - Accounting | 02 Jul 2021, 16:01 |
| APLS | Apellis Pharmaceuticals, Inc. | 11 Jun 2021 | 3 | -$58,355 | 4 | Vice President - Accounting | 15 Jun 2021, 16:04 |
| APLS | Apellis Pharmaceuticals, Inc. | 01 Jun 2021 | 3 | -$52,640 | 4 | Vice President - Accounting | 02 Jun 2021, 16:15 |